Clinical Trials · NCT03357380
A Study on How Semaglutide Works on Early Stages of Scar Tissue in the Liver Assessed by Pictures of the Liver
- Phase
- Phase 1
- Recruitment status
- Completed
- Sponsor
- Novo Nordisk A/S
- Enrollment
- 67
- Start date
- Nov 2017
- Locations
- 2 sites, Germany
- Primary endpoint
- Change in liver stiffness (kPa) assessed by magnetic resonance elastography (MRE)